Black Rock Inc. Organovo Holdings, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 142,208 shares of ONVO stock, worth $56,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares

142,208

Previous 142,208 -0.0%

Holding current value

$56,883

Previous $146,000 26.03%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.9 - $1.17 $4,781 - $6,216	-5,313 Reduced 3.6%	142,208 $146,000
Q4 2023 Feb 13, 2024	BUY	$1.05 - $1.84 $168 - $294	160 Added 0.11%	147,521 $163,000
Q3 2023 Nov 13, 2023	BUY	$1.06 - $1.9 $108 - $193	102 Added 0.07%	147,361 $184,000
Q2 2023 Aug 11, 2023	BUY	$1.64 - $2.24 $72 - $98	44 Added 0.03%	147,259 $248,000
Q1 2023 May 12, 2023	SELL	$1.44 - $3.2 $208 - $464	-145 Reduced 0.1%	147,215 $322,000
Q4 2022 Feb 13, 2023	SELL	$1.41 - $2.17 $260 - $401	-185 Reduced 0.13%	147,360 $209,000
Q3 2022 Nov 14, 2022	SELL	$1.76 - $3.55 $505 - $1,018	-287 Reduced 0.19%	147,545 $303,000
Q2 2022 Aug 12, 2022	SELL	$1.71 - $3.71 $33,003 - $71,603	-19,300 Reduced 11.55%	147,832 $262,000
Q1 2022 May 12, 2022	SELL	$2.74 - $4.41 $2,909 - $4,683	-1,062 Reduced 0.63%	167,132 $629,000
Q4 2021 Feb 10, 2022	BUY	$3.63 - $6.86 $4,043 - $7,642	1,114 Added 0.67%	168,194 $611,000
Q3 2021 Nov 09, 2021	BUY	$6.08 - $8.92 $8,366 - $12,273	1,376 Added 0.83%	167,080 $1.14 Million
Q2 2021 Aug 11, 2021	BUY	$6.65 - $9.95 $1.1 Million - $1.65 Million	165,704 New	165,704 $1.56 Million

Others Institutions Holding ONVO

# of Institutions

Shares Held

2.44M

Call Options Held

17K

Put Options Held

View Full List

About ORGANOVO HOLDINGS, INC.

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $3.48M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

More about ONVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account